[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:unipolar-depression":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":308,"states":313},"Unipolar Depression",312,231,[8,16,23,29,35,41,47,54,60,66,72,78,84,90,96,102,108,115,121,127,133,139,145,150,156,161,167,173,178,184,190,196,202,207,213,219,225,231,237,243,249,255,261,267,273,278,284,290,296,302],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07284667","ACP-211 Monotherapy for Major Depressive Disorder With Inadequate Antidepressant Response",[12],"Phase 2","RECRUITING","2026-08-26T02:19:02.550788Z","2026-07-19T19:36:05.069478Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06564818","\"A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder\"",[20],"Phase 3","2026-08-03T00:58:09.398304Z","2026-07-05T05:32:16.761464Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT06547489","Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder",[12],"2026-08-26T02:16:44.178623Z","2026-07-05T05:32:16.760940Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT05977439","RECOVERS - Realigning Emotion and COgnition Via prEcision Regulation networkS",[],"2026-08-26T02:15:48.613507Z","2026-07-05T05:32:16.739261Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT07104916","Mindfulness-based Psilocybin Therapy for PTSD",[12],"2026-08-26T02:15:56.561131Z","2026-07-05T05:32:16.734103Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT06793397","A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder",[20],"2026-08-26T02:18:01.700186Z","2026-07-05T05:32:16.694734Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":52,"content_modified":53},"NCT07266545","RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)",[51],"Phase 4","2026-08-26T02:17:35.666428Z","2026-07-05T04:52:06.752829Z",{"nct_id":55,"title":56,"phases":57,"status":13,"updated_at":58,"content_modified":59},"NCT07226232","Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression",[20],"2026-08-26T02:18:11.042248Z","2026-06-16T05:54:07.936175Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":64,"content_modified":65},"NCT07022405","Stratified Pharmacological Approaches for Regulating Circuit-Level Effects",[12],"2026-08-26T02:18:43.501109Z","2026-06-16T05:54:07.930925Z",{"nct_id":67,"title":68,"phases":69,"status":13,"updated_at":70,"content_modified":71},"NCT07621237","A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)",[12],"2026-08-26T02:17:34.833510Z","2026-06-04T01:30:07.905529Z",{"nct_id":73,"title":74,"phases":75,"status":13,"updated_at":76,"content_modified":77},"NCT07610473","A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression",[12],"2026-08-26T02:16:01.079019Z","2026-05-29T15:36:40.227863Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT07592689","A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)",[20],"2026-08-26T02:18:21.216897Z","2026-05-29T15:36:40.202387Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":88,"content_modified":89},"NCT07230990","Mechanisms Of Orbitofrontal Stimulation in Depression",[],"2026-08-26T02:17:12.307088Z","2026-05-29T15:36:40.182862Z",{"nct_id":91,"title":92,"phases":93,"status":13,"updated_at":94,"content_modified":95},"NCT07573176","A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder",[20],"2026-08-26T02:16:46.147215Z","2026-05-13T02:55:06.778713Z",{"nct_id":97,"title":98,"phases":99,"status":13,"updated_at":100,"content_modified":101},"NCT07572526","tDCS: Sleep to Mood in Depression (S2M-D)",[],"2026-08-26T02:17:27.435233Z","2026-05-13T02:55:06.735477Z",{"nct_id":103,"title":104,"phases":105,"status":13,"updated_at":106,"content_modified":107},"NCT07512284","Mindfulness Engaged Neurostimulation for Depression (MEND II)",[12],"2026-08-26T02:18:08.005333Z","2026-05-13T02:55:06.711848Z",{"nct_id":109,"title":110,"phases":111,"status":13,"updated_at":113,"content_modified":114},"NCT02994433","NMDA Receptor Antagonist Nitrous Oxide Targets Affective Brain Circuits",[112],"Phase 1","2026-08-26T02:19:16.454910Z","2026-05-13T02:55:06.105165Z",{"nct_id":116,"title":117,"phases":118,"status":13,"updated_at":119,"content_modified":120},"NCT06559306","Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms",[20],"2026-08-26T02:15:17.167444Z","2026-05-05T02:43:29.735279Z",{"nct_id":122,"title":123,"phases":124,"status":13,"updated_at":125,"content_modified":126},"NCT02122562","Ketamine Alcohol (in Treatment-Resistant Depression)",[12],"2026-08-26T02:17:14.343713Z","2026-05-05T02:43:29.722832Z",{"nct_id":128,"title":129,"phases":130,"status":13,"updated_at":131,"content_modified":132},"NCT05239780","Invasive Decoding and Stimulation of Altered Reward Computations in Depression Patients",[],"2026-08-26T02:18:00.873391Z","2026-05-05T02:43:29.702074Z",{"nct_id":134,"title":135,"phases":136,"status":13,"updated_at":137,"content_modified":138},"NCT03887715","A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression",[],"2026-08-26T02:15:11.740957Z","2026-05-05T02:43:29.701000Z",{"nct_id":140,"title":141,"phases":142,"status":13,"updated_at":143,"content_modified":144},"NCT06938841","Maintenance rTMS for Depression (Maitr-De)",[],"2026-08-26T02:19:08.862440Z","2026-05-05T02:43:29.683001Z",{"nct_id":146,"title":147,"phases":148,"status":13,"updated_at":88,"content_modified":149},"NCT07219394","Peer-Delivered Behavioral Activation in a CCBHC",[],"2026-05-05T02:43:29.680660Z",{"nct_id":151,"title":152,"phases":153,"status":13,"updated_at":154,"content_modified":155},"NCT07025720","Accelerated Intermittent Theta Burst Stimulation for Adolescent and Young Adult Depression With Elevated Suicide Risk",[],"2026-08-26T02:15:40.343619Z","2026-05-05T02:43:29.587115Z",{"nct_id":157,"title":158,"phases":159,"status":13,"updated_at":131,"content_modified":160},"NCT07490782","Nutritional Intervention for College Students With Depression",[],"2026-05-05T02:43:29.586058Z",{"nct_id":162,"title":163,"phases":164,"status":13,"updated_at":165,"content_modified":166},"NCT06656416","ALTO-100 in Bipolar Disorder With Depression (BD-D)",[12],"2026-08-26T02:16:24.970704Z","2026-05-05T02:43:29.579548Z",{"nct_id":168,"title":169,"phases":170,"status":13,"updated_at":171,"content_modified":172},"NCT06963021","NBI-1065845-MDD3026: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)",[20],"2026-08-26T02:17:30.961790Z","2026-05-05T02:43:29.541162Z",{"nct_id":174,"title":175,"phases":176,"status":13,"updated_at":113,"content_modified":177},"NCT05892744","Establishing Multimodal Brain Biomarkers for Treatment Selection in Depression",[51],"2026-05-05T02:43:29.521504Z",{"nct_id":179,"title":180,"phases":181,"status":13,"updated_at":182,"content_modified":183},"NCT07553637","ALTO-207 in Adults With Treatment-resistant Depression (TRD)",[12],"2026-08-26T02:16:27.227548Z","2026-05-05T02:43:29.504655Z",{"nct_id":185,"title":186,"phases":187,"status":13,"updated_at":188,"content_modified":189},"NCT06580145","Leucine in Midlife Depression",[12],"2026-08-26T02:15:37.042762Z","2026-05-05T02:43:29.504168Z",{"nct_id":191,"title":192,"phases":193,"status":13,"updated_at":194,"content_modified":195},"NCT07159061","Neurofeedback to Treat Depression - 2",[],"2026-08-26T02:17:32.059863Z","2026-05-05T02:43:29.482186Z",{"nct_id":197,"title":198,"phases":199,"status":13,"updated_at":200,"content_modified":201},"NCT07076407","A Randomized Study of Azetukalner Versus Placebo in Major Depressive Disorder (X-NOVA3)",[20],"2026-08-26T02:19:26.493949Z","2026-05-05T02:43:29.474300Z",{"nct_id":203,"title":204,"phases":205,"status":13,"updated_at":52,"content_modified":206},"NCT06223880","A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms",[51],"2026-05-05T02:43:29.471485Z",{"nct_id":208,"title":209,"phases":210,"status":13,"updated_at":211,"content_modified":212},"NCT06728774","Cognitive Rehabilitation for Veterans With MDD-related Cognitive Functioning Deficits",[],"2026-08-26T02:16:06.684983Z","2026-05-05T02:43:29.409855Z",{"nct_id":214,"title":215,"phases":216,"status":13,"updated_at":217,"content_modified":218},"NCT06982820","Self Neuro-modulation Therapy for Major Depressive Disorder (MDD) With Anhedonia",[],"2026-08-26T02:16:57.705506Z","2026-05-05T02:43:29.397052Z",{"nct_id":220,"title":221,"phases":222,"status":13,"updated_at":223,"content_modified":224},"NCT03065335","Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder",[112],"2026-08-26T02:19:20.945539Z","2026-05-05T02:43:29.393419Z",{"nct_id":226,"title":227,"phases":228,"status":13,"updated_at":229,"content_modified":230},"NCT07221929","Exercise-priming of CBT for Depression: the CBT+ Trial",[],"2026-08-26T02:19:19.162260Z","2026-05-05T02:43:29.389938Z",{"nct_id":232,"title":233,"phases":234,"status":13,"updated_at":235,"content_modified":236},"NCT07095205","PET Imaging Using the Tracer [18F]VAT to Assess the Antidepressant Effect of Nicotine.",[51],"2026-08-26T02:18:47.742071Z","2026-05-05T02:43:29.283031Z",{"nct_id":238,"title":239,"phases":240,"status":13,"updated_at":241,"content_modified":242},"NCT06559826","Ketamine-Assisted Psychotherapy (KAP) Compared to Ketamine Alone for the Treatment of Depression",[12],"2026-08-26T02:17:06.985283Z","2026-05-05T02:43:29.231368Z",{"nct_id":244,"title":245,"phases":246,"status":13,"updated_at":247,"content_modified":248},"NCT07217444","Improving Outcomes in Adolescent Inpatient Depression With Deep Transcranial Magnetic Stimulation",[],"2026-08-26T02:18:29.369233Z","2026-05-05T02:43:29.202841Z",{"nct_id":250,"title":251,"phases":252,"status":13,"updated_at":253,"content_modified":254},"NCT05925322","Brain Changes During Social Reward Psychotherapy for Mid- and Late-Life Suicidality",[],"2026-08-26T02:16:11.347936Z","2026-05-05T02:43:29.196000Z",{"nct_id":256,"title":257,"phases":258,"status":13,"updated_at":259,"content_modified":260},"NCT05757791","Sodium-Glucose Cotransporter-2 Inhibitor (SGLT2) in Major Depressive Disorder (MDD)",[12],"2026-08-26T02:16:20.336282Z","2026-05-05T02:43:29.194194Z",{"nct_id":262,"title":263,"phases":264,"status":13,"updated_at":265,"content_modified":266},"NCT07065240","A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)",[12],"2026-08-26T02:18:38.865010Z","2026-05-05T02:43:29.171273Z",{"nct_id":268,"title":269,"phases":270,"status":13,"updated_at":271,"content_modified":272},"NCT06512194","Investigation to Understand and Optimize Psilocybin",[12],"2026-08-26T02:19:07.104270Z","2026-05-05T02:43:29.168900Z",{"nct_id":274,"title":275,"phases":276,"status":13,"updated_at":253,"content_modified":277},"NCT04004169","Closed-Loop Deep Brain Stimulation for Major Depression",[],"2026-05-05T02:43:29.168879Z",{"nct_id":279,"title":280,"phases":281,"status":13,"updated_at":282,"content_modified":283},"NCT05450432","Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With Depression",[51],"2026-08-26T02:17:59.904383Z","2026-05-05T02:43:29.153658Z",{"nct_id":285,"title":286,"phases":287,"status":13,"updated_at":288,"content_modified":289},"NCT07143838","Enhancing Slow Wave Sleep in Depression",[],"2026-08-26T02:15:57.572488Z","2026-05-05T02:43:29.022554Z",{"nct_id":291,"title":292,"phases":293,"status":13,"updated_at":294,"content_modified":295},"NCT05553353","Dosing rTMS for Depression Post-SCI",[],"2026-08-26T02:15:44.309045Z","2026-05-05T02:43:28.966683Z",{"nct_id":297,"title":298,"phases":299,"status":13,"updated_at":300,"content_modified":301},"NCT06423430","Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)",[],"2026-08-26T02:17:23.750999Z","2026-05-05T02:43:28.900579Z",{"nct_id":303,"title":304,"phases":305,"status":13,"updated_at":306,"content_modified":307},"NCT05004987","Aβ Dynamics in LLMD",[51],"2026-08-26T02:17:21.315591Z","2026-05-05T02:43:28.866314Z",[309],{"biomarker":310,"count":311,"slug":312},"CRP Gene",5,"crp-gene",[314,318,322,326,330,334,337,341,345,349,353,357,361,364,368,372,375,379,383,387,390,393,396,400],{"state":315,"count":316,"slug":317},"California",99,"california",{"state":319,"count":320,"slug":321},"New York",80,"new-york",{"state":323,"count":324,"slug":325},"Massachusetts",67,"massachusetts",{"state":327,"count":328,"slug":329},"Texas",65,"texas",{"state":331,"count":332,"slug":333},"Georgia",48,"georgia",{"state":335,"count":332,"slug":336},"Ohio","ohio",{"state":338,"count":339,"slug":340},"Florida",47,"florida",{"state":342,"count":343,"slug":344},"Pennsylvania",42,"pennsylvania",{"state":346,"count":347,"slug":348},"Maryland",36,"maryland",{"state":350,"count":351,"slug":352},"Illinois",34,"illinois",{"state":354,"count":355,"slug":356},"Washington",33,"washington",{"state":358,"count":359,"slug":360},"Missouri",25,"missouri",{"state":362,"count":359,"slug":363},"North Carolina","north-carolina",{"state":365,"count":366,"slug":367},"Connecticut",24,"connecticut",{"state":369,"count":370,"slug":371},"Alabama",23,"alabama",{"state":373,"count":370,"slug":374},"Oklahoma","oklahoma",{"state":376,"count":377,"slug":378},"Utah",22,"utah",{"state":380,"count":381,"slug":382},"Nevada",21,"nevada",{"state":384,"count":385,"slug":386},"Arizona",20,"arizona",{"state":388,"count":385,"slug":389},"Arkansas","arkansas",{"state":391,"count":385,"slug":392},"Colorado","colorado",{"state":394,"count":385,"slug":395},"South Carolina","south-carolina",{"state":397,"count":398,"slug":399},"New Jersey",19,"new-jersey",{"state":401,"count":398,"slug":402},"Tennessee","tennessee"]